3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Oropharyngeal Neoplasms
4
Head and Neck Neoplasms
3
Rectal Neoplasms
2
Pathologic Complete Response
2
Lung Neoplasms
2
Glioblastoma
2
Uterine Cervical Neoplasms
1
Tobacco Use Disorder
1
Thymoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Smoking
1
Sinonasal undifferentiated carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Rectal Malignant Neoplasms
1
Radiation Injuries
1
Postoperative Complications
1
Paranasal Sinus Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Mouth Neoplasms
1
Low Anterior Resection Syndrome
1
Laryngeal Neoplasms
1
Infiltrating Bladder Urothelial Carcinoma
1
HPV-Related Squamous Cell Carcinoma
1
Fatigue
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Interventions
Cisplatin
18
Gemcitabine
14
Radiotherapy, Intensity-Modulated
11
Magnetic Resonance Spectroscopy
8
toripalimab
7
Specimen Handling
7
Capecitabine
7
Platinum
5
Drug Therapy
5
1,2-diaminocyclohexaneplatinum II citrate
5
camrelizumab
4
Radiotherapy
4
Nivolumab
4
spartalizumab
3
sintilimab
3
anlotinib
3
Immunoglobulin G
3
Immune Checkpoint Inhibitors
3
Docetaxel
3
Disulfides
3
atezolizumab
2
Radiation
2
Phantoms, Imaging
2
Ipilimumab
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
Bevacizumab
2
18-O-demethylcervinomycin A2
2
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
Chemoradiotherapy
×
90 days
×
Clear all
No trials found.